Andrew Reardon
Officer at LGND
Data refreshed: Aug 22, 2026, 11:46 PM UTC
Total filings
21
Buys
0
$0
Sells
18
$3.0M
Grants & other
0
$0
Recent filings
| Filed | Symbol | Type | Qty | Value |
|---|---|---|---|---|
| Aug 4, 2026 | LGND Ligand Pharmaceuticals Inc | OTHER | 5,000 | $261K |
| Aug 4, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 105 | $30K |
| Aug 4, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 33 | $9K |
| Aug 4, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 157 | $45K |
| Aug 4, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 1,032 | $296K |
| Aug 4, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 1,214 | $349K |
| Aug 4, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 356 | $103K |
| Aug 4, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 503 | $146K |
| Aug 4, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 200 | $58K |
| Aug 4, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 991 | $289K |
| Aug 4, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 409 | $120K |
| Jul 6, 2026 | LGND Ligand Pharmaceuticals Inc | OTHER | 5,000 | $261K |
| Jul 6, 2026 | LGND Ligand Pharmaceuticals Inc | OTHER | 132 | $21K |
| Jul 6, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 396 | $122K |
| Jul 6, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 1,081 | $338K |
| Jul 6, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 1,119 | $349K |
| Jul 6, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 700 | $219K |
| Jul 6, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 104 | $32K |
| Jul 6, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 900 | $284K |
| Jul 6, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 100 | $31K |
| Jul 6, 2026 | LGND Ligand Pharmaceuticals Inc | SELL | 600 | $190K |